Kunming Longjin Pharmaceutical Co Ltd (002750) — Cash Flow Reinvestment Rate

Latest as of December 2022: 146.78x

Kunming Longjin Pharmaceutical Co Ltd (002750) has a Cash Flow Reinvestment Rate of 146.78x as of December 2022, reinvesting CN¥127.33 Million (capex CN¥5.41 Million plus investments CN¥121.93 Million) from operating cash flow of CN¥867.54K. See cash generation quality of Kunming Longjin Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

146.78x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥127.33 Million
Capex + Investments

Operating Cash Flow

CN¥867.54K
CNY

Capital Expenditures

CN¥5.41 Million
CNY

Kunming Longjin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2011–2019)

Historical reinvestment intensity for Kunming Longjin Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Kunming Longjin Pharmaceutical Co Ltd generate cash.

Annual Cash Flow Reinvestment Rate for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)

Year-by-year capital reinvestment analysis for Kunming Longjin Pharmaceutical Co Ltd. See 002750 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2019 49.98x CN¥202.07 Million CN¥4.04 Million CN¥7.07 Million ▲ +399.9%
2018 10.00x CN¥316.91 Million CN¥31.70 Million CN¥15.53 Million ▲ +1264.5%
2017 0.73x CN¥42.54 Million CN¥58.06 Million CN¥17.54 Million ▼ -67.5%
2016 2.25x CN¥235.06 Million CN¥104.24 Million CN¥23.56 Million ▼ -18.4%
2015 2.76x CN¥193.93 Million CN¥70.19 Million CN¥23.93 Million ▲ +949.5%
2014 0.26x CN¥18.47 Million CN¥70.16 Million CN¥18.47 Million ▼ -52.9%
2013 0.56x CN¥59.57 Million CN¥106.46 Million CN¥59.57 Million ▼ -31.2%
2012 0.81x CN¥74.14 Million CN¥91.16 Million CN¥74.14 Million ▼ -33.5%
2011 1.22x CN¥92.79 Million CN¥75.90 Million CN¥92.79 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow